Linda A. Fitzpatrick - Mar 4, 2022 Form 4 Insider Report for SUTRO BIOPHARMA, INC. (STRO)

Role
Chief People & Comm. Officer
Signature
/s/ Edward C. Albini as attorney-in-fact for Linda A. Fitzpatrick
Stock symbol
STRO
Transactions as of
Mar 4, 2022
Transactions value $
-$24,281
Form type
4
Date filed
3/7/2022, 06:28 PM
Previous filing
Feb 1, 2022
Next filing
Jan 31, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STRO Common Stock Options Exercise +8.75K +28.65% 39.3K Mar 5, 2022 Direct F1
transaction STRO Common Stock Tax liability -$24.3K -2.97K -7.56% $8.17 36.3K Mar 5, 2022 Direct F2
holding STRO Common Stock 10.4K Mar 4, 2022 Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997 F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STRO Stock Option (right to buy Common Stock) Award $0 +42K $0.00 42K Mar 4, 2022 Common Stock 42K $8.17 Direct F4
transaction STRO Restricted Stock Unit (RSU) Award $0 +36.5K $0.00 36.5K Mar 4, 2022 Common Stock 36.5K Direct F1, F5
transaction STRO Restricted Stock Unit (RSU) Options Exercise $0 -8.75K -25% $0.00 26.3K Mar 5, 2022 Common Stock 8.75K Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each RSU represents a contingent right to receive one (1) share of the issuer's Common Stock upon settlement.
F2 Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the RSUs and does not represent a sale by the reporting person.
F3 These securities are held of record by Michael A. Fitzpatrick and Linda A. Fitzpatrick, Trustees of the Michael A. & Linda A. Fitzpatrick Family Trust dated 10/13/1997.
F4 The option vests as to 2.0833% of the total shares monthly, beginning on April 4, 2022, with 100% of the total shares vested and exercisable on March 4, 2026, subject to the reporting person's provision of service to the issuer on each vesting date.
F5 The RSUs vest as to 1/4th of the total shares annually beginning on March 4, 2023, subject to continued service through each vesting date.
F6 The RSUs vest as to 1/4th of the total shares annually beginning on March 5, 2022, subject to continued service through each vesting date.